Constitutive androstane receptor ligands modulate the anti-tumor efficacy of paclitaxel in non-small cell lung cancer cells.

<h4>Background</h4>Lung tumors are the leading cause of cancer deaths worldwide and paclitaxel has proven to be useful for patients with lung cancer, however, acquired resistance is a major problem. To overcome this problem, one promising option is the use of Constitutive Androstane Rece...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Heidge Fukumasu, Arina L Rochetti, Pedro R L Pires, Edson R Silva, Ligia G Mesquita, Ricardo F Strefezzi, Daniel D De Carvalho, Maria L Dagli
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2014
Materias:
R
Q
Acceso en línea:https://doaj.org/article/e564eb23803c4938b2a290a345db19ef
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!